Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (5)

2017

  1. Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

    Stem Cell Reports, Vol. 8, Núm. 5, pp. 1392-1407

2014

  1. Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

    British journal of cancer, Vol. 111, Núm. 6, pp. 1060-1064

2011

  1. Evidence for a link between TNFRSF11A and risk of breast cancer

    Breast Cancer Research and Treatment, Vol. 129, Núm. 3, pp. 947-954

  2. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

    PLoS Biology, Vol. 9, Núm. 11

2010

  1. Biological reprogramming in acquired resistance to endocrine therapy of breast cancer

    Oncogene, Vol. 29, Núm. 45, pp. 6071-6083